Clinical trials for Breast cancer
191 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
#NCT07007559
HER2 Positive
Metastatic
1
2
3 or more
4 recruiting sites
ALX Oncologie Inc
Phase 2
Breast cancer
#NCT06680596
#2024-515349-41-00
HER2 Low
HR Positive
Metastatic
None
Antibody Drug Conjugates (ADC)
Hormone therapy
34 recruiting sites
UNICANCER
Phase 2
Breast cancer
#NCT05955170
#2022-500743-20-00
HER2 Positive
Metastatic
1
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
9 recruiting sites
Institut Curie
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT03767075
#2024-514238-19-00
Module 2 bras 2B, Module 3 bras 3A et 3C
Locally Advanced
Metastatic
Metastatic Castration-resistant
EGFR
FGFR
MET
1
2
3 or more
Systemic Treatment-Naive
1 recruiting site
Institut d'oncologie du Vall d'Hebron
Phase 2
Breast cancer
#NCT06486883
HER2 Low
HR Positive
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
5 recruiting sites
MedSIR
Phase 2
Breast cancer
#NCT06172478
#2023-507641-29-00
Cancer du sein
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
Chemotherapy
Targeted therapy
Hormone therapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
9 recruiting sites
Daiichi Sankyo
Phase 2
Breast cancer
#NCT04985266
Phase de surveillance de l’ADN tumoral circulant
HER2 Negative
HR Positive
Localized
None
Surgery
Chemotherapy
Hormone therapy
Targeted therapy
18 recruiting sites
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Breast cancer
#NCT07193394
#2024-519624-24-00
HER2 Negative
Locally Advanced
Metastatic
Other mutation
2
3 or more
Chemotherapy
Hormone therapy
1 recruiting site
Institut Curie
Phase 2
Breast cancer
#NCT03424005
#2023-503629-20-00
HER2 Low
HER2 Positive
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
2
3 or more
Systemic Treatment-Naive
2 recruiting sites
Hoffmann-La Roche
Phase 2
Breast cancer
#NCT04965766
#2023-505923-30-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Chemotherapy
Targeted therapy
Hormone therapy
10 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris